Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bio Light Headed for Biggest Gain in Month on Glaucoma Permit

March 22 (Bloomberg) -- Bio Light Israeli Life Sciences Investments Ltd. headed for its biggest gain in more than a month after the developer of drugs and medical technology said a unit got approval to market a glaucoma surgery device.

The shares advanced 2.1 percent, headed for the biggest gain since Feb. 21, to 0.197 shekel at 11 a.m. in Tel Aviv, giving the Ramat Gan, Israel-based company a market value of 35 million shekels ($9.3 million).

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at

To contact the editor responsible for this story: Claudia Maedler at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.